The Cigna Group (NYSE: CI) reported third quarter 2023 earnings results today. Total revenues increased 8% to $49 billion compared to the same
Cigna Group (CI) Q3 2023 Earnings: Key financials and quarterly highlights
Categories
Health Care
Earnings Summary: A snapshot of IQVIA Holdings’ Q3 2023 results
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
CVS Health (CVS) Q3 2023 Earnings: Key financials and quarterly highlights
CVS Health Corporation (NYSE: CVS) reported third quarter 2023 earnings results today. Total revenues increased 10.6% year-over-year to $89.8 billion. Net income
Key takeaways from Pfizer’s (PFE) Q3 2023 earnings results
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter of 2023.
AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company
PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2023 financial results
Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a
BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also provided guidance
Merck (MRK) Earnings: 3Q23 Key Numbers
Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year
ABBV Earnings: A snapshot of AbbVie’s Q3 2023 report
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income. The company reported
Key highlights from Thermo Fisher’s (TMO) Q3 2023 earnings results
Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2023 earnings results today. Revenue dropped 1% year-over-year to $10.57 billion. Organic revenues
Earnings Summary: Highlights of Centene Corp’s Q3 2023 earnings report
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced third-quarter 2023 earnings results, reporting a sharp increase in revenues and adjusted
Ocean Biomedical’s chief scientist Dr. Jonathan Kurtis receives Falk Award for malaria drug candidate
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its chief scientist, Jonathan Kurtis MD, PhD has received the prestigious Falk
Intuitive Surgical stock dips after mixed Q3 earnings. What’s in store?
Intuitive Surgical, Inc. (NASDAQ: ISRG) produces and sells some of the most advanced robotic surgical systems that make medical procedures simpler and
ISRG Earnings: Intuitive Surgical Q3 2023 revenues and earnings increase
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the third quarter of 2023, reporting higher revenues and adjusted
Infographic: Key highlights from Abbott Laboratories’ (ABT) Q3 2023 earnings results
Abbott Laboratories (NYSE: ABT) reported third quarter 2023 earnings results today. Net sales decreased 2.6% year-over-year to $10.1 billion. On an organic basis,
JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported third quarter 2023 earnings results today. Reported sales increased 6.8% year-over-year to $21.3 billion. Operational sales
Infographic: How UnitedHealth Group (UNH) performed in Q3 2023
UnitedHealth Group (NYSE: UNH) reported third quarter 2023 earnings results today. Revenues grew 14% year-over-year to $92.4 billion. Net earnings attributable to
Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand the latter’s
Walgreens Boots Alliance (WBA) Q4 2023 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2023 earnings results today. Sales increased 9.2% year-over-year to $35.4 billion. Sales growth
Johnson & Johnson to report earnings on Oct 17. Here’s what to look for
After reporting better-than-expected quarterly earnings consistently for over a decade, healthcare behemoth Johnson & Johnson (NYSE: JNJ) is preparing to release its
UnitedHealth earnings preview: Another beat in cards despite cost concerns
Over the years, UnitedHealth Group Incorporated (NYSE: UNH) has expanded steadily through diversification and acquisitions, all along creating value for shareholders. The